Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Neuroendocrine tumor therapy:
177
Lu-DOTATATE
Erik S. Mittra
Diagnostic Radiology
Research output
:
Contribution to journal
›
Article
›
peer-review
73
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Neuroendocrine tumor therapy:
177
Lu-DOTATATE'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Neuroendocrine Tumors
100%
Peptide Receptors
27%
Radioisotopes
22%
Gastro-enteropancreatic neuroendocrine tumor
17%
Theranostic Nanomedicine
14%
Therapeutics
14%
Somatostatin
11%
Congresses
10%
Progression-Free Survival
10%
Patient Selection
9%
Direction compound
8%
Clinical Trials
7%
Quality of Life
7%
Survival
6%
Neoplasms
3%